Evidence map›Paper›PMID 21403835›Full record

ArticleNeoplasia (New York, N.Y.)2011

Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research.

John Kurhanewicz, Daniel B Vigneron, Kevin Brindle, Eduard Y Chekmenev, Arnaud Comment, Charles H Cunningham, Ralph J Deberardinis, Gary G Green, Martin O Leach, Sunder S Rajan and 4 more

Abstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 397 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
397citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

397 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Glycolytic pathway candidate markers in the prognosis of oral squamous cell carcinoma: a systematic review with meta-analysis.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Pooled it
  2. A Static Phantom for Harmonization of Hyperpolarized [1-Magnetic resonance in medicine · 2026
    Article
  3. Article
  4. High-resolution microtesla in-situJournal of magnetic resonance (San Diego, Calif. : 1997) · 2026
    Article
  5. Complementary hyperpolarizedNpj imaging · 2026
    Article
  6. Article
  7. Review
  8. 14.1 T Liquid-StateJournal of the American Chemical Society · 2026
    Article
  9. Review
  10. Article
  11. Multidimensional pH-Temperature Mapping of SABRE-SHEATHThe journal of physical chemistry. B · 2025
    Article
  12. Article
  13. Article
  14. Distance-Dependence of Photo-CIDNP in Biomimetic Tryptophan-Flavin Diads.Angewandte Chemie (International ed. in English) · 2025
    Article
  15. EfficientJournal of magnetic resonance open · 2025
    Article
  16. Article
  17. Toward Generalized Solution-StateThe journal of physical chemistry letters · 2025
    Article
  18. Hyperpolarized [1-Scientific reports · 2025
    Article
  19. Parahydrogen-Hyperpolarized Propane-The journal of physical chemistry. A · 2025
    Article
  20. Article

337 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

John KurhanewiczDepartment of Radiology and Biomedical Imaging, University of California at San Francisco, San Francisco, CA 94158-2330, USA. John.Kurhanewicz@radiology.ucsf.edu
Daniel B Vigneron
Kevin Brindle
Eduard Y Chekmenev
Arnaud Comment
Charles H Cunningham
Ralph J Deberardinis
Gary G Green
Martin O Leach
Sunder S Rajan
Rahim R Rizi
Brian D Ross
Warren S Warren
Craig R Malloy

Funding

YTTRIUM HYPERPOLARIZATIONP41RR002584 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI MASON, RALPH P. · 1985 to 2011
$14.3M
Intermolecular Multiple-Quantum Coherence Effects in NMRR01EB002122 · NIBIB · PRINCETON UNIVERSITY · PI WARREN, WARREN S · 2003 to 2013
$2.8M
NCRR NIH HHS P41 RR002584NIBIB NIH HHS R01 EB002122
6 · The paper itself

Abstract

A major challenge in cancer biology is to monitor and understand cancer metabolism in vivo with the goal of improved diagnosis and perhaps therapy. Because of the complexity of biochemical pathways, tracer methods are required for detecting specific enzyme-catalyzed reactions. Stable isotopes such as (13)C or (15)N with detection by nuclear magnetic resonance provide the necessary information about tissue biochemistry, but the crucial metabolites are present in low concentration and therefore are beyond the detection threshold of traditional magnetic resonance methods. A solution is to improve sensitivity by a factor of 10,000 or more by temporarily redistributing the populations of nuclear spins in a magnetic field, a process termed hyperpolarization. Although this effect is short-lived, hyperpolarized molecules can be generated in an aqueous solution and infused in vivo where metabolism generates products that can be imaged. This discovery lifts the primary constraint on magnetic resonance imaging for monitoring metabolism-poor sensitivity-while preserving the advantage of biochemical information. The purpose of this report was to briefly summarize the known abnormalities in cancer metabolism, the value and limitations of current imaging methods for metabolism, and the principles of hyperpolarization. Recent preclinical applications are described. Hyperpolarization technology is still in its infancy, and current polarizer equipment and methods are suboptimal. Nevertheless, there are no fundamental barriers to rapid translation of this exciting technology to clinical research and perhaps clinical care.

Indexed as

Biomarkers, TumorCarbon IsotopesFumaratesHumansMagnetic Resonance ImagingMetabolic Networks and PathwaysNeoplasmsPositron-Emission TomographyPyruvic AcidBiomarkers, TumorCarbon IsotopesFumaratesPyruvic Acid

Identifiers

PMID21403835
PMCPMC3033588

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.